MSJ888610_supplementary_material – Supplemental material for Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies

Comi, Giancarlo; Alroughani, Raed; Boster, Aaron L; Bass, Ann D; Berkovich, Regina; Fernández, Óscar; Kim, Ho Jin; Limmroth, Volker; Lycke, Jan; Macdonell, Richard AL; Sharrack, Basil; Singer, Barry A; Vermersch, Patrick; Wiendl, Heinz; Ziemssen, Tjalf; Jacobs, Alan; Daizadeh, Nadia; Rodriguez, Claudio E; Traboulsee, Anthony

doi:10.25384/SAGE.11200958.v1

MSJ888610_supplementary_material.pdf (707.98 kB)

MSJ888610_supplementary_material – Supplemental material for Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies

journal contribution

posted on 2019-11-26, 13:08 authored by Giancarlo Comi, Raed Alroughani, Aaron L Boster, Ann D Bass, Regina Berkovich, Óscar Fernández, Ho Jin Kim, Volker Limmroth, Jan Lycke, Richard AL Macdonell, Basil Sharrack, Barry A Singer, Patrick Vermersch, Heinz Wiendl, Tjalf Ziemssen, Alan Jacobs, Nadia Daizadeh, Claudio E Rodriguez, Anthony Traboulsee

Supplemental material, MSJ888610_supplementary_material for Efficacy of alemtuzumab in relapsing-remitting MS patients who received additional courses after the initial two courses: Pooled analysis of the CARE-MS, extension, and TOPAZ studies by Giancarlo Comi, Raed Alroughani, Aaron L Boster, Ann D Bass, Regina Berkovich, Óscar Fernández, Ho Jin Kim, Volker Limmroth, Jan Lycke, Richard AL Macdonell, Basil Sharrack, Barry A Singer, Patrick Vermersch, Heinz Wiendl, Tjalf Ziemssen, Alan Jacobs, Nadia Daizadeh, Claudio E Rodriguez and Anthony Traboulsee in Multiple Sclerosis Journal